Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Top 20 APAC insurers maintain momentum with 8.2% average premium growth amid COVID-19 impact in 2022, reveals GlobalData

The top 20 public insurance companies in Asia-Pacific (APAC) sustained their momentum in 2022, benefiting from the increased insurance awareness following the COVID-19 pandemic and an economic rebound in most markets. As a result, their average premium earned* grew by 8.2% while experiencing a marginal 0.7% uptick in total revenue, reveals GlobalData, a leading data […]
Read more

English Premier League front-of-shirt rights see $71.79 million investment from betting brands with 35% market share, reveals GlobalData

As the curtain rises on the 2023-24 English Premier League season, the realm of front-of-shirt sponsorships takes center stage. Among the 18 active teams in the topflight, seven have forged significant partnerships with betting brands. This trend, backed by a noteworthy investment of $71.79 million and a market share of 35%, underscores the dynamic intersection […]
Read more

Arm IPO success hinges on Softbank ability to convince investors Arm is an AI company, says GlobalData

Following the news that Softbank-backed British chip designing giant Arm is set to launch an initial public offering (IPO) early in September 2023: Mike Orme, Consultant Analyst, Thematic Intelligence at GlobalData, offers his view: “For Softbank to justify its target $64 billion Nasdaq valuation at next month’s IPO, it must persuade investors that Arm is […]
Read more

Financial distress in digital health apps linked to market shifts and rising interest rates, finds GlobalData

As technology continues its transformative journey across sectors, healthcare apps emerge as beacons of progress, promising enhanced health management and accessibility. Amid this promising landscape, challenges loom for healthcare app enterprises. The convergence of rising funding costs and shifting market dynamics puts these companies at risk of financial instability, potentially leading to insolvency, says GlobalData, […]
Read more

Global deal activity down by 23.6% YoY during January to July 2023, reveals GlobalData

Amidst a landscape fraught with macroeconomic uncertainty, the first seven months of 2023 proved challenging for deal activity (mergers & acquisitions (M&A), private equity (PE) and venture financing), with firms contending with the ripple effects of escalating interest rates and an ambiguous economic horizon. This struggle unfolded alongside a broader narrative of global deal activity, […]
Read more

Top 20 global biopharmaceutical companies report 2.3% market cap growth in Q2 2023, reveals GlobalData

Despite the continued inflationary pressures, the second quarter (Q2) of 2023 yielded promising outcomes for the leading 20 biopharmaceutical giants. The aggregate market capitalization demonstrated a resilient upswing of 2.3%, surging from $3.49 trillion during the first quarter (Q1) of 2023 to an impressive $3.56 trillion in Q2 2023, reveals GlobalData, a leading data and […]
Read more

Travel and tourism industry deal activity decline by 35.7% YoY in January-July 2023, reveals GlobalData

US and UK saw respective deal volume reducing to almost half China emerges as notable exception Amidst a backdrop of challenging market conditions, various industries have grappled with subdued deal activity during January-July 2023. The travel and tourism industry is no different and saw deal activity decline by a massive year-on-year (YoY) 35.7%, reveals GlobalData, […]
Read more

Opportunity for first indigenous South Korea SGLT-2 and metformin combination therapy to go global, says GlobalData

Daewoong Pharmaceutical recently obtained approvals for its indigenous therapies—sodium–glucose linked transporter-2 (SGLT-2) inhibitor Envlo (enavogliflozin) and its metformin combination drug Envlomet—in South Korea. As prescription trends tilt in favor of SGLT-2 combination therapies globally, the domestic innovator has an opportunity to compete with the established SGLT-2 combination therapies from multinational companies, says GlobalData, a leading […]
Read more

Australia medical devices market to reach $14 billion in 2030, forecasts GlobalData

Driven by the growing demand for personalized and patient-focused healthcare, advancements in technology, and rapid evolution and implementation of artificial intelligence (AI) in healthcare, Australia’s medical devices market is anticipated to reach $14 billion in 2030, says GlobalData, a leading data and analytics company. GlobalData’s research reveals that Australia accounts for over 6% of the […]
Read more

GlobalData highlights complexity of regenerative medicine landscape

In modern healthcare, regenerative medicine has emerged as a beacon of hope, offering innovative treatments and therapies that utilize the power of genetic engineering to address previously untreatable diseases. While the potential benefits are undeniable, the landscape has challenges that demand careful consideration, says GlobalData, a leading data and analytics company. Cynthia Stinchcombe, Medical Analyst […]
Read more

RingCentral ramps up AI-powered portfolio but needs unique draw to outshine rivals, says GlobalData

RingCentral, a US-based provider of AI-powered global enterprise cloud communications, video meetings, collaboration, and contact center solutions, has recently expanded its artificial intelligence (AI) platform “RingSense” across its portfolio. However, there remains a need for a compelling draw that can entice customers away from competitors such as Cisco, Zoom, Microsoft and Google, according to GlobalData, […]
Read more
1 … 93 94 95 96 97 … 209